Engineering metal-organic frameworks as precision nanomedicines for myocardial infarction therapy.
4 affiliations
- 1Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266000, China.
- 2Anhui University of Technology (Xiushan Campus), No. 1530 Maxiang Road, Anhui, 243032, Ma'anshan, China.
- 3The First Affiliated Hospital of Hebei North University, No. 12 Changqing Road, Qiaoxi District, Zhangjiakou, 075061, Hebei, China. [email protected].
- 4Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266000, China. [email protected].
Abstract
Myocardial infarction (MI) remains a major cause of mortality worldwide. However, current therapeutic paradigms are limited in their ability to modulate the post-infarction pathological microenvironment with spatiotemporal precision. Metal-organic frameworks (MOFs), an emerging class of crystalline porous coordination polymers, offer exceptional structural programmability through their ultra-high specific surface areas, tunable pore architectures, and customizable surface chemistries. These properties have positioned MOFs as promising platforms for targeted MI therapy. In this review, the molecular design principles for constructing MOFs as precise nanomedicines for myocardial infarction are examined. Structural strategies-including stimulus-responsive drug delivery, biomimetic nanoplatforms, theranostic systems, and biohybrid constructs-are systematically analyzed with respect to their capacity to modulate the post-infarction microenvironment. The mechanisms underlying MOF-mediated cardiac repair are critically evaluated, with emphasis on oxidative stress regulation, inflammatory microenvironment reprogramming, and angiogenesis promotion. Key translational barriers, including biosafety assessment, scalable manufacturing, delivery-route optimization, and validation in large-animal models, are also discussed. Finally, future directions involving multi-omics-guided architectural design, organ-on-chip technology, 3D-printed cardiac patches, regulatory science, and a testable research agenda are proposed. Although MOF-based MI therapies remain at the preclinical stage, these convergent efforts may accelerate the bench-to-bedside translation of MOF-based precision nanomedicines for cardiovascular disease.
Related
- Cell-derived biomimetic nanomedicines: Emerging theranostic platforms for precision management of atherosclerosis.
- Engineering Natural Product Nanomedicines to Modulate Tumor Immunometabolism for Enhanced Cancer Immunotherapy
- Synergistic Pore Microenvironment Engineering in Zinc Metal–Organic Frameworks for High SF 6 /N 2 Selectivity and Humidity‐Resistant Trace SF 6 Capture
- Metal-organic and covalent organic frameworks for precision drug delivery: a precision-by-design evidence framework for biologically accountable nanomedicine.
- Integrated proteomics and machine learning for identifying candidate serum biomarkers in acute myocardial infarction-complicated cardiogenic shock: a prospective exploratory study
BibTeX
@article{liu2026engineering,
title = {{Engineering metal-organic frameworks as precision nanomedicines for myocardial infarction therapy.}},
author = {Kaijing Liu and Yuguang Liu and Aiai Zhang and Xiaolei Han},
journal = {Discover nano},
year = {2026},
month = oct,
doi = {10.1186/s11671-026-05038-y},
url = {https://europepmc.org/article/MED/42895610},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Engineering metal-organic frameworks as precision nanomedicines for myocardial infarction therapy.
AU - Kaijing Liu
AU - Yuguang Liu
AU - Aiai Zhang
AU - Xiaolei Han
PY - 2026
DA - 2026/10/19
JO - Discover nano
DO - 10.1186/s11671-026-05038-y
UR - https://europepmc.org/article/MED/42895610
AB - Myocardial infarction (MI) remains a major cause of mortality worldwide. However, current therapeutic paradigms are limited in their ability to modulate the post-infarction pathological microenvironment with spatiotemporal precision. Metal-organic frameworks (MOFs), an emerging class of crystalline porous coordination polymers, offer exceptional structural programmability through their ultra-high specific surface areas, tunable pore architectures, and customizable surface chemistries. These properties have positioned MOFs as promising platforms for targeted MI therapy. In this review, the molecular design principles for constructing MOFs as precise nanomedicines for myocardial infarction are examined. Structural strategies-including stimulus-responsive drug delivery, biomimetic nanoplatforms, theranostic systems, and biohybrid constructs-are systematically analyzed with respect to their capacity to modulate the post-infarction microenvironment. The mechanisms underlying MOF-mediated cardiac repair are critically evaluated, with emphasis on oxidative stress regulation, inflammatory microenvironment reprogramming, and angiogenesis promotion. Key translational barriers, including biosafety assessment, scalable manufacturing, delivery-route optimization, and validation in large-animal models, are also discussed. Finally, future directions involving multi-omics-guided architectural design, organ-on-chip technology, 3D-printed cardiac patches, regulatory science, and a testable research agenda are proposed. Although MOF-based MI therapies remain at the preclinical stage, these convergent efforts may accelerate the bench-to-bedside translation of MOF-based precision nanomedicines for cardiovascular disease.
SN - 2731-9229
ER -